N-Acetylaspartate: A Unique Neuronal Molecule in the Central Nervous System (Advances in Experimental Medicine and Biology)

Moffett, John R., Ph.D. (Editor)/ Tieman, Suzannah B., Ph.D. (Editor)/ Weinberger, Daniel R. (Editor)/ Coyle, Joseph T. (Editor)

ISBN 10: 0387301712 / ISBN 13: 9780387301716

Edité par Springer Verlag, 2006

A propos de cet article

1st edition. 376 pages. 9.50x6.50x0.75 inches. In Stock.

N° de réf. du vendeur x-0387301712

Détails bibliographiques

• Titre: N-Acetylaspartate: A Unique Neuronal Molecule in the Central Nervous System (Advances in Experimental Medicine and Biology)
• Éditeur: Springer Verlag
• Date de parution: 2006
• Langue: anglais
• ISBN à 10 chiffres: 0387301712
• ISBN à 13 chiffres: 9780387301716
• Reliure: Hardcover
• État de l'article: Brand New
• Poids: 0,72 kilogramme

A propos de ce titre

Synopsis

N-acetylaspartate, or NAA, is the acetylated form of the amino acid aspartate, and it is present exclusively in the nervous system. Indeed, NAA is one of the most highly concentrated chemicals found in the brain of humans and animals, and yet the functions served by this brain-specific metabolite remain elusive, and controversial. Despite the uncertainties surrounding the functions of NAA in the development and operation of the nervous system, this molecule has attracted the attention of researchers and clinicians for two distinct reasons.

First, the acetyl proton on NAA gives off a very prominent signal in water-suppressed, proton magnetic resonance spectroscopy (MRS), which permits clinicians to monitor levels of NAA in the brains of patients in a non-invasive manner. Because NAA is found primarily in neurons, and because the levels in the brain have been found to change rapidly after injury, or slowly during neurodegenerative diseases, MRS has become a preferred method of analyzing nerve cell dysfunction and death without surgical intervention.

The second reason that NAA has attracted attention in recent years is that a congenital genetic disorder of NAA metabolism has been found to be the cause of the neurodegenerative disorder known as Canavan's disease. Canavan's disease is an inherited leukodystrophy that involves myelination pathologies of cortical white matter, leading to death within 10 years of birth. The genetic mutation results in a defective enzyme that de-acetylates NAA in the brain, resulting in a significant rise in NAA levels in the brain and urine. This enzyme, known as aspartoacylase (ASPA), appears to be involved in the process of myelination, such that a defective enzyme results in a disruption of the myelination of nerve fibers during development.

The purpose of this symposium is to bring together investigators from around the world who are interested in the study of NAA, and the roles it plays in neuronaldevelopment and functioning. It is hoped that bringing researchers and clinicians together in such a forum will facilitate rapid progress in this emerging field, and will help lead to discoveries that can alleviate the suffering caused by a deadly, inheritable infantile disease.